Prospective study of postoperative magnetic resonance imaging in patients with malignant gliomas

Journal of Clinical Oncology

Volumn 15, Issue 5, 1997, Pages 2076-2081

  Forsyth, P A ^a   Petrov, E ^a   Mahallati, H ^a   Cairncross, J G ^a   Brasher, P ^a   MacRae, M E ^a   Hagen, N A ^a   Barnes, P ^a   Sevick, R J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GADOLINIUM PENTETATE MEGLUMINE; METHEMOGLOBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG TOLERANCE; FEMALE; GLIOBLASTOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; TUMOR VOLUME;

EID: 0031005804     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1997.15.5.2076     Document Type: Article

References (19)

1. Cairncross JG, Warwick Pexman JH, Rathbone MP, et al: Postoperative contrast enhancement in patients with brain tumor. Ann Neurol 17:570-572, 1985
2. Cairncross JG, Warwick Pexman JH, Rathbone MP: Post-surgical contrast enhancement mimicking residual brain tumor. Cdn J Neurol Sci 12:75, 1985
3. Wiener MD, Boyko OB, Friedman HS, et al: False-positive spinal MR findings for subarachnoid spread of primary CNS tumor in postoperative pediatric patients. Am J Neuroradiol 11:1100-1103, 1990
4. Mokri B, Krueger R, Miller GM, et al: Meningeal gadolinium enhancement in low pressure headaches. Ann Neurol 30:294-295, 1991
5. Pannullo SC, Reich JB, Krol G, et al: MRI changes in intracranial hypotension. Neurology 43:919-926, 1993
6. Mokri B, Parisi JE, Scheithauer BW, et al: Meningeal biopsy in intracranial hypotension: Meningeal enhancement on MRI. Neurology 45:1801-1807, 1995
7. Watling C, Lee D, Macdonald D, et al: Steroid-induced MR scan changes in patients with recurrent malignant glioma. J Clin Oncol 12:1886-1889, 1994
8. Albert FK, Forsting M, Sartor K, et al: Early postoperative magnetic resonance imaging after resection of malignant glioma: Objective evaluation of residual tumor and its influence on regrowth and prognosis. Neurosurgery 34:45-60, 1994
9. Bronen RA, Sze G: Magnetic resonance imaging contrast agents: Theory and application to the central nervous system. J Neurosurg 73:820-839, 1990
10. Sze G, Berry I, Brant-Zawadzki M, et al: Gadolinium-DTPA in the magnetic resonance evaluation of the postoperative patient. Acta Radiologica 369:568-571, 1986
11. Henegar MM, Moran CJ, Silbergeld DL: Early postoperative magnetic resonance imaging following non-neoplastic cortical resection. J Neurosurg 84:174-179, 1996
12. Cairncross JG, Macdonald DR, Pexman JHW, et al: Steroid induced CT scan changes in patients with recurrent malignant glioma. Neurology 38:724-726, 1988
13. Niendorf HP, Haustein J, Cornelius I, et al: Safety of gadolinium-DTPA: Extended clinical experience. Magn Res Med 22:222-228, 1991
14. Goldstein HA, Kashanian FK, Blumetti RF, et al: Safety assessment of gadopentetate dimeglumine in US clinical trials. Radiology 174:17-23, 1990
15. Lufkin RB: Severe anaphylactoid reaction to Gd-DTPA. Radiology 176:879, 1990
16. Takebayashi S, Sugiyama M, Nagase M, et al: Severe adverse reaction to IV gadopenetate dimeglumine. Am J Roentgenol 160:659, 1993 (letter)
17. Omohundro JE, Elderbrook MK, Ringer IV: Laryngospasm after administration of gadopentelate dimeglumine. J Magn Res Imaging 2:729-730, 1992
18. Tischler S, Hoffman JC: Anaphylactoid reactions to IV gadopentetate dimeglumine. Am J Neuroradiol 11:1167, 1990 (letter)
19. Weiss KL: Severe anaphylactoid reaction after IV Gd-DTPA. Magn Reson Imaging 8:817-818, 1990